Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 379Triple Negative Breast Neoplasms 61Ovarian Neoplasms 46Prostatic Neoplasms 35Colorectal Neoplasms 35Neoplasms 28Carcinoma, Non-Small-Cell Lung 27Endometrial Neoplasms 24Lung Neoplasms 22Neoplasm Metastasis 21Uterine Cervical Neoplasms 19Melanoma 18Stomach Neoplasms 17Pancreatic Neoplasms 16Squamous Cell Carcinoma of Head and Neck 15Carcinoma, Renal Cell 14Urinary Bladder Neoplasms 13Sarcoma 12Head and Neck Neoplasms 12Esophageal Neoplasms 11Colonic Neoplasms 10Advanced Breast Cancer 9Small Cell Lung Carcinoma 8Carcinoma, Transitional Cell 8Anatomic Stage I Breast Cancer AJCC v8 8Liver Neoplasms 7Kidney Neoplasms 7Cholangiocarcinoma 7Carcinoma, Hepatocellular 6Brain Neoplasms 6

Interventions

palbociclib 1Letrozole 1Fulvestrant 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Breast Neoplasm Female × Breast × 30 days × Clear all
NCT05417516 2026-05-22

A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)

Ontario Clinical Oncology Group (OCOG)

Phase 3 Recruiting
910 enrolled
Breast

Breast Neoplasm Female

NCT03425838 2026-05-20

Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

Borstkanker Onderzoek Groep

Phase 3 Active not recruiting
1,050 enrolled
Breast

Breast Neoplasm Female

NCT06499077 2026-05-15

BreathBC

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Active not recruiting
1,000 enrolled
Breast

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡